Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20020 (
adenosine triphosphatase
)
3,299
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Epithelial calcium transport occurs by paracellular and transcellular mechanisms. Transcellular transport in intestinal and renal epithelia involves several transport proteins, including transient receptor potential vanilloid member 5 (TRPV5), member 6 (
TRPV6
), calbindin D9k (CB9), calbindin D28k (CB28), sodium calcium exchanger 1 (NCX1),
plasma membrane calcium ATPase 1
(
PMCA1
), and the vitamin D receptor (VDR). We are interested in the horse because of its unique calcium physiology (high blood calcium, high intestinal calcium absorption, high renal excretion of calcium, low vitamin D concentrations), and because horses often have dysregulated calcium balance with various diseases. We cloned the mRNA for equine TRPV5,
TRPV6
, CB9, CB28, NCX1,
PMCA1
, and VDR, performed comparative mRNA and protein sequence analysis, and quantified their mRNA expression in the kidney and gastrointestinal tract. Sequence homology for the mRNAs and proteins was high among mammals (>75%), with fish having the lowest homology (<75%). TRPV5,
TRPV6
, and CB9 expression was higher in the duodenum and proximal jejunum and followed a similar expression pattern. CB28 expression was greatest in the kidney.
PMCA1
and NCX1 expression was similar throughout the intestine, but in the kidney
PMCA1
expression was higher. Based on our findings, the proximal small intestine is the main site for transcellular calcium transport, with
TRPV6
and CB9 serving as the main transport proteins. In the kidney,
TRPV6
, CB28, and
PMCA1
are likely more important. The low VDR expression in the equine small intestine and kidney relative to the large intestine, together with the reported high intestinal absorption and renal excretion of calcium, and low vitamin D concentrations suggests that epithelial calcium transport in horses is not as dependent on vitamin D as in other species.
...
PMID:Cloning, comparative sequence analysis and mRNA expression of calcium-transporting genes in horses. 2022 85
This study investigated the effect of dexamethasone (DEX) on intracellular calcium levels and the expressions of transient receptor potential cation channel subcomponent V member 6 (
TRPV6
), sodium-calcium exchanger 1 (
NCX1
), and
plasma membrane calcium ATPase 1
(
PMCA1
) in A549 cells. The intracellular calcium level, by using the calcium indicator pGP-CMV-GCaMP6f, increased following DEX treatment for 6, 12, and 24 h in A549 cells. In addition, Rhod-4 assay after DEX treatment for 24 h showed that DEX increased the level of intracellular calcium. The expression of the calcium influx
TRPV6
gene significantly increased, whereas the expressions of the calcium outflow
NCX1
and
PMCA1
genes significantly decreased with DEX treatment. The mRNA levels of surfactant protein genes
SFTPA1
,
SFTPB
,
SFTPC
, and
SFTPD
and the secreted airway mucin genes
MUC1
and
MUC5AC
were investigated by treating cells with DEX. The DEX treatment decreased the mRNA levels of
SFTPA1
and
SFTPB
but increased the mRNA levels of
SFTPC
and
SFTPD
. The
MUC1
mRNA level was increased by DEX treatment, whereas
MUC5AC
mRNA was significantly decreased. These results indicate that DEX influences the intracellular calcium level through
TRPV6
, and affects pulmonary surfactant genes and secreted airway mucin genes in A549 cells.
...
PMID:Dexamethasone Treatment Increases the Intracellular Calcium Level Through
TRPV6
in A549 Cells. 3203 37